The legal medical cannabis movement
Health Europa explores the various approaches to medical cannabis, as more and more countries around the world move in favour of legalisation.
With medical cannabis...
The changing face of medical cannabis in Denmark
Cannabis Danmark CEO Rikke Jakobsen reflects on what the new medical cannabis pilot and development programmes mean for patients, growers and healthcare professionals in...
Tilray gains US Government approval to import a medical cannabis study drug
Import of pharmaceutical grade medical cannabis produced by Tilray® Inc has been approved by the US Drug Enforcement Administration (DEA), with a special study...
Tilray exports 2:100 CBD oil to the United Kingdom
Tilray® Inc., a global leader in cannabis research, production and distribution, announced today that Tilray 2:100, a product produced at Tilray’s federally licensed, Good Manufacturing...
Putting patients first by making cannabinoid medicinal products available
Tilray makes cannabinoid medicinal products available to patients in a time frame that matters and urges others to do the same
Focusing on patients, their...
Cannabis could be used to treat inflammatory bowel diseases
New findings suggest an ingredient in marijuana could mimic the body’s inflammation off-switch, potentially leading to a new drug targeting different types of bowel...
The Canadian Cannabis Act: what does it mean for legalisation elsewhere?
In a history-making political decision, Canada is currently preparing for the legalisation of recreational cannabis, known as the Cannabis Act, which would make it...
Are women being advised to use cannabis to treat morning sickness?
A new study from Denver Health in the US has found that 69% of dispensaries advised a researcher posing as a pregnant woman to...
Health Europa Quarterly Issue 05
Health Europa Quarterly issue 05 outlines the ongoing debate regarding the legalisation of medical cannabis in Europe and the work being done across the...
Survey reveals medical cannabis reduced painkiller use in older adults
A new study has revealed using medical cannabis (or marijuana) substantially reduced chronic pain and dependence on opioid painkillers in 65% of older adults.
Researchers...
Legalising medical cannabis – a German perspective
Germany legalised medical cannabis in March 2017; more than a year on, why are some patients still going without? Georg Wurth shares his thoughts.
Medical...
Medical Cannabis Bike Tour funds glioblastoma clinical trial
Tim Lay and Dr Jonathan Newman explain how a European bike tour is boosting research, challenging assumptions and winning support in the journey towards...
A centre of excellence for medical cannabis research
The Czech Republic-based International Cannabis and Cannabinoids Institute is making an invaluable contribution to medical cannabis research worldwide, as Dr Ethan Russo tells Health...
European journal calls for medical cannabis to be mainstream
In a new special issue of the European Journal of Internal Medicine, researchers are calling for medical cannabis to be properly established in the...
Towards legalisation
As more and more countries legalise the use of cannabis for medical purposes, Health Europa Quarterly highlights recent research into its possible therapeutic benefits.
The...
